Andrzej Sawicki

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine · 2001 · 4.6K citations

Medicine, Endocrinology, Bone Metabolism +16

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

T. J. de Villiers, Arkadi Chines, Santiago Palacios et al. · Osteoporosis International · 2010 · 135 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +12

Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk Factors

Christian Roux, Jean‐Yves Reginster, J. Fechtenbaum et al. · Journal of Bone and Mineral Research · 2006 · 130 citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover

Richard Eastell, R.A. Hannon, Dietrich Wenderoth et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 87 citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16